Literature DB >> 17076529

Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.

Eva-Marie Chong1, Robert E Coffee, Murali Chintagumpala, Richard L Hurwitz, Mary Y Hurwitz, Patricia Chévez-Barrios.   

Abstract

CONTEXT: Retinoblastoma is the most common malignant intraocular tumor in children. It has been shown that adjuvant therapy following enucleation in patients with high-risk histopathologic features significantly decreases the mortality. We describe the association of extensive necrosis of tumor and intraocular structures with 2 of the major risk factors: optic nerve invasion and choroidal invasion. This may alert the pathologist who makes the observation of extensive necrosis to carefully search for histologic features associated with adverse outcome.
OBJECTIVE: To determine whether extensively necrotic retinoblastoma is associated with high-risk histologic prognostic factors for metastatic disease and patient survival.
DESIGN: Retrospective case series. Forty-three eyes of 43 patients with retinoblastoma who underwent enucleation between 1990 and 2001 were evaluated. Medical records, histopathology specimens, pathology reports, and clinical photographs were reviewed. Tumors were designated as exhibiting extensive necrosis if more than 95% of tumor cells and intraocular tissues were necrotic. The main outcome measure was the association of extensive tumor necrosis with 3 high-risk histopathologic features: extraocular extension, optic nerve invasion, or choroidal invasion. Metastatic disease, patient survival, and associations with pathologic findings were also analyzed.
RESULTS: Optic nerve head invasion (P < .001), post-lamina-cribrosal invasion (P < .001), and choroidal invasion by tumor (P = .004) were observed more frequently in eyes with extensive necrosis compared with eyes without extensive necrosis. Two of the 11 patients with extensively necrotic intraocular retinoblastoma died from metastatic disease (P = .06). None of the 32 patients without extensive necrosis developed metastatic disease or died.
CONCLUSIONS: Extensive ocular tissue and tumor necrosis is associated with histologic high-risk prognostic factors for tumor metastasis and mortality.

Entities:  

Mesh:

Year:  2006        PMID: 17076529     DOI: 10.5858/2006-130-1669-ENRIAW

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 1: MRI vs. histopathology.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Petra Temming; Michael M Schuendeln; Sophia L Goericke
Journal:  Neuroradiology       Date:  2015-06-04       Impact factor: 2.804

Review 2.  Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

Authors:  Daniel M Green; Larry E Kun; Katherine K Matthay; Anna T Meadows; William H Meyer; Paul A Meyers; Sheri L Spunt; Leslie L Robison; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2013-02-15       Impact factor: 3.167

3.  The value of "en toto" globe submission in the assessment of high-risk retinoblastoma cases and staging.

Authors:  Hind Manaa Alkatan; Hani ALBalawi; Azza M Y Maktabi
Journal:  Int Ophthalmol       Date:  2017-03-14       Impact factor: 2.031

Review 4.  Current treatment and management of retinoblastoma.

Authors:  Dan S Gombos; And Patricia Chevez-Barrios
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

5.  Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study.

Authors:  La-Ongsri Atchaneeyasakul; Chutima Wongsiwaroj; Mongkol Uiprasertkul; Kleebsabai Sanpakit; Kullathorn Thephamongkhol; Adisak Trinavarat
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

6.  Diagnostic image quality of gadolinium-enhanced T1-weighted MRI with and without fat saturation in children with retinoblastoma.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Michael M Schuendeln; Simone Lohbeck; Andrej Krasny; Sophia L Goericke
Journal:  Pediatr Radiol       Date:  2013-01-13

7.  Retinoblastoma major review with updates on Middle East management protocols.

Authors:  Ihab Saad Othman
Journal:  Saudi J Ophthalmol       Date:  2012-04

Review 8.  Risk definition and management strategies in retinoblastoma: current perspectives.

Authors:  Fariba Ghassemi; Alireza Khodabande
Journal:  Clin Ophthalmol       Date:  2015-06-08

9.  Clinicopathological Findings of Retinoblastoma: A 10-Year Experience from a Tertiary Hospital in Kampala, Uganda.

Authors:  James Joseph Yahaya; Belson Rugwizangoga; Alex Mremi; Asafu Munema
Journal:  J Ophthalmol       Date:  2019-06-16       Impact factor: 1.909

10.  Chemotherapy induced histopathological changes in retinoblastoma, assessment of high risk predictive factors & its correlation with comorbid conditions.

Authors:  Nausheen Yaqoob; Salima Mansoor; Nida Zia; Kanwal Aftab; Bushra Kaleem; Saba Jamal
Journal:  Pak J Med Sci       Date:  2022-01       Impact factor: 1.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.